ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Rodgers Brothers Inc.

Rodgers Brothers Inc. cut its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 71.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,255 shares of the company’s stock after selling 51,364 shares during the quarter. Rodgers Brothers Inc. owned 0.07% of ZimVie worth $334,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ZIMV. Scarborough Advisors LLC acquired a new position in ZimVie during the fourth quarter worth about $28,000. Heritage Wealth Advisors boosted its stake in shares of ZimVie by 172,750.0% during the 1st quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock worth $114,000 after acquiring an additional 6,910 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of ZimVie by 27.2% in the 4th quarter. SG Americas Securities LLC now owns 14,152 shares of the company’s stock worth $251,000 after acquiring an additional 3,029 shares during the period. Bailard Inc. purchased a new position in ZimVie in the 4th quarter valued at approximately $254,000. Finally, Teton Advisors Inc. acquired a new position in ZimVie during the fourth quarter worth $266,000. Institutional investors and hedge funds own 95.63% of the company’s stock.

ZimVie Trading Down 0.2 %

Shares of NASDAQ ZIMV traded down $0.04 on Friday, reaching $21.67. 410,117 shares of the company traded hands, compared to its average volume of 346,414. The stock has a market capitalization of $591.37 million, a PE ratio of -1.55 and a beta of 2.17. ZimVie Inc. has a fifty-two week low of $6.52 and a fifty-two week high of $22.40. The company has a current ratio of 2.68, a quick ratio of 2.23 and a debt-to-equity ratio of 1.32. The company has a 50 day moving average of $17.74 and a 200 day moving average of $17.44.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings data on Wednesday, May 8th. The company reported $0.08 earnings per share (EPS) for the quarter. The company had revenue of $118.20 million during the quarter. ZimVie had a negative net margin of 56.31% and a positive return on equity of 2.01%. During the same period in the prior year, the firm earned $0.25 earnings per share. On average, equities research analysts forecast that ZimVie Inc. will post 0.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Needham & Company LLC restated a “buy” rating and set a $20.00 target price on shares of ZimVie in a report on Tuesday, June 25th.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.